Code only confirmed cases of HIV infection/illness. This is an exception to the hospital inpatient guideline Section II, H. In this context, “confirmation” does not require documentation of positive serology or culture for HIV; the provider’s diagnostic statement that the patient is HIV positive or has an HIV-related illness is sufficient.
B08.5
BookmarkEnteroviral vesicular pharyngitis
Filed alongside this entry 777
under Syndrome
- 4H G11.5
- 5q minus NOS D46.C
- 22q13.3 deletion Q93.52
- 48,XXXX Q97.1
- 49,XXXXX Q97.1
- abnormal innervation H02.519
- abstinence, neonatal P96.1
- acid pulmonary aspiration, obstetric O74.0
- activated phosphoinositide 3-kinase delta syndrome [APDS] D81.82
- acute abdominal R10.0
- acute respiratory distress (adult) (child) J80
- Adair-Dighton Q78.0
- Adams-Stokes (-Morgagni) I45.9
- adiposogenital E23.6
- adrenogenital E25.9
- afferent loop NEC K91.89
- Aicardi-Goutières E79.81
- Alagille (-Watson) Q44.71
- Alder's D72.0
- Aldrich (-Wiskott) D82.0
- alien hand R41.4
- Alpha-gal Z91.014
- Alport Q87.81
- alveolar hypoventilation E66.2
- alveolocapillary block J84.10
- amyostatic (Wilson's disease) E83.01
- androgen insensitivity E34.50
- androgen resistance E34.50
- Angelman Q93.51
- ankyloglossia superior Q38.1
- antibody deficiency D80.9
- anticardiolipin (-antibody) D68.61
- antidepressant discontinuation T43.205
- antiphospholipid (-antibody) D68.61
- aortomesenteric duodenum occlusion K31.5
- apical ballooning (transient left ventricular) I51.81
- arcuate ligament I77.4
- argentaffin, argintaffinoma E34.09
- Arrillaga-Ayerza I27.0
- arterial tortuosity Q87.82
- arteriovenous steal T82.898
- Asherman's N85.6
- ataxia-telangiectasia G11.3
- auriculotemporal G50.8
- autoerythrocyte sensitization (Gardner-Diamond) D69.2
- autoimmune polyglandular E31.0
- autoimmune lymphoproliferative [ALPS] D89.82
- autoinflammatory M04.9
- Avellis' G46.8
- Axenfeld-Rieger Q13.81
- Ayerza (-Arrillaga) I27.0
- Babinski-Nageotte G83.89
- Bakwin-Krida Q78.5
- Bardet-Biedl Q87.83
- bare lymphocyte D81.6
- Barré-Guillain G61.0
- Barré-Liéou M53.0
- Barsony-Polgar K22.4
- Barsony-Teschendorf K22.4
- Barth E78.71
- Bartter's E26.81
- basal cell nevus Q87.89
- Basedow's E05.00
- basilar artery G45.0
- Batten-Steinert G71.11
- Beals Q87.40
- Beau's I51.5
- Beck's I65.8
- Benedikt's G46.3
- Béquez César (-Steinbrinck-Chédiak-Higashi) E70.330
- Berardinelli-Siep E88.12
- big spleen D73.1
- bilateral polycystic ovarian E28.2
- Birt-Hogg-Dube syndrome Q87.89
- Björck (-Thorsen) E34.09
- Blackfan-Diamond D61.01
- Blau M04.8
- blind loop K90.2
- blue sclera Q78.0
- blue toe I75.02
- Boder-Sedgewick G11.3
- Boerhaave's K22.3
- Borjeson Forssman Lehmann Q89.89
- Bouillaud's I01.9
- Bourneville (-Pringle) Q85.1
- Bouveret (-Hoffman) I47.9
- brachial plexus G54.0
- bradycardia-tachycardia I49.5
- brain (nonpsychotic) F09
- brain stem stroke G46.3
- Brandt's (acrodermatitis enteropathica) E83.2
- BRCA1-cancer predisposition QA1.790
- BRCA2-cancer predisposition QA1.791
- broad ligament laceration N83.8
- Brock's J98.11
- bronchiolitis obliterans J44.81
- bronze baby P83.88
- Brown-Sequard G83.81
- Brugada I49.81
- bubbly lung P27.0
- Buchem's M85.2
- Budd-Chiari I82.0
- bulbar (progressive) G12.22
- Bürger-Grütz E78.3
- Burke's K86.89
- Burnett's (milk-alkali) E83.52
- burning feet E53.9
- Bywaters' T79.5
- Call-Fleming I67.841
- cannabinoid hyperemesis R11.16
- cannabis hyperemesis R11.16
- carbohydrate-deficient glycoprotein (CDGS) E77.8
- carcinogenic thrombophlebitis I82.1
- carcinoid E34.00
- cardiac asthma I50.1
- cardiacos negros I27.0
- cardiofaciocutaneous Q87.89
- cardiopulmonary-obesity E66.2
- cardiorespiratory distress (idiopathic) , newborn P22.0
- carpal tunnel G56.0
- Cassidy (-Scholte) E34.09
- cat cry Q93.4
- cat eye Q92.8
- cauda equina G83.4
- celiac K90.0
- central pain G89.0
- cervical (root) M53.1
- cervicobrachial (diffuse) M53.1
- cervicocranial M53.0
- cervicodorsal outlet G54.2
- cervicothoracic outlet G54.0
- Céstan (-Raymond) I65.8
- Charcot's (angina cruris) (intermittent claudication) I73.9
- Charcot-Weiss-Baker G90.09
- CHARGE Q89.89
- Chédiak-Higashi (-Steinbrinck) E70.330
- chest wall R07.1
- Chiari's (hepatic vein thrombosis) I82.0
- Chilaiditi's Q43.3
- chondrocostal junction M94.0
- chondroectodermal dysplasia Q77.6
- chromosome 4 short arm deletion Q93.3
- chromosome 5 short arm deletion Q93.4
- Churg-Strauss M30.1
- Clarke-Hadfield K86.89
- Clerambault's automatism G93.89
- clinically isolated G37.9
- Clouston's (hidrotic ectodermal dysplasia) Q82.4
- clumsiness, clumsy child F82
- cluster headache G44.009
- Coffin-Lowry Q89.89
- cold injury (newborn) P80.0
- combined immunity deficiency D81.9
- compartment (deep) (posterior) (traumatic) T79.A0
- compression T79.5
- concussion F07.81
- congestion-fibrosis (pelvic) , female N94.89
- congestive dysmenorrhea N94.6
- Conn's E26.01
- connective tissue M35.9
- conus medullaris G95.81
- Costen's (complex) M26.69
- costochondral junction M94.0
- costoclavicular G54.0
- costovertebral E22.0
- craniovertebral M53.0
- cri-du-chat Q93.4
- crib death R99
- croup J05.0
- crush T79.5
- CTNNB1 Q87.88
- Curschmann (-Batten) (-Steinert) G71.11
- Cushing's E24.9
- cryopyrin-associated periodic M04.2
- cryptophthalmos Q87.0
- cystic duct stump K91.5
- cytokine release D89.839
- Dana-Putnam D51.0
- Danbolt (-Cross) (acrodermatitis enteropathica) E83.2
- Dandy-Walker Q03.1
- Danlos' Q79.60
- Degos' I77.89
- Déjérine-Roussy G89.0
- delayed sleep phase G47.21
- demyelinating G37.9
- depersonalization (-derealization) F48.1
- De Quervain E34.51
- de Toni-Fanconi (-Debré) E72.09
- de Vivo syndrome E74.810
- diabetes mellitus in newborn infant P70.2
- dialysis associated steal T82.898
- Diamond-Blackfan D61.01
- Diamond-Gardener D69.2
- DIC (diffuse or disseminated intravascular coagulopathy) D65
- di George's D82.1
- Dighton's Q78.0
- disequilibrium E87.8
- Döhle body-panmyelopathic D72.0
- dorsolateral medullary G46.4
- double athetosis G80.3
- Down Q90.9
- Dravet (intractable) G40.834
- Dresbach's (elliptocytosis) D58.1
- DRESS (drug rash with eosinophilia and systemic symptoms) D72.12
- Dressler's (postmyocardial infarction) I24.1
- drug rash with eosinophilia and systemic symptoms (DRESS) D72.12
- drug withdrawal, infant of dependent mother P96.1
- dry eye H04.12
- dumping (postgastrectomy) K91.1
- Dupré's (meningism) R29.1
- dysmetabolic X E88.810
- dyspraxia, developmental F82
- Eagle-Barrett Q79.4
- Ebstein's Q22.5
- ectopic ACTH E24.3
- eczema-thrombocytopenia D82.0
- Eddowes' Q78.0
- effort (psychogenic) F45.8
- Eisenmenger's I27.83
- Ehlers-Danlos Q79.60
- Ekman's Q78.0
- electric feet E53.8
- Ellis-van Creveld Q77.6
- empty nest Z60.0
- endocrine-hypertensive E27.0
- eosinophilia-myalgia M35.89
- Erdheim-Chester (ECD) E88.89
- Erdheim's E22.0
- erythrocyte fragmentation D59.4
- Evans D69.41
- exhaustion F48.8
- extrapyramidal G25.9
- eyelid-malar-mandible Q87.0
- Faber's D50.9
- facet M47.89
- facet joint M47.819
- facial pain, paroxysmal G50.0
- Fallot's Q21.3
- familial cold autoinflammatory M04.2
- familial eczema-thrombocytopenia (Wiskott-Aldrich) D82.0
- Fanconi (-de Toni) (-Debré) E72.09
- faulty bowel habit K59.39
- Feil-Klippel (brevicollis) Q76.1
- fertile eunuch E23.0
- Fiedler's I40.1
- first arch Q87.0
- fish odor E72.89
- Fisher's G61.0
- Fitz's K85.80
- Flajani (-Basedow) E05.00
- flush E34.09
- Foix-Alajouanine G95.19
- Fong's Q87.2
- food protein-induced enterocolitis (FPIES) K52.21
- foramen magnum G93.5
- Foster-Kennedy H47.14
- Foville's (peduncular) G46.3
- FOXG1 QA0.0151
- fragile X Q99.2
- Franceschetti Q75.4
- Friderichsen-Waterhouse A39.1
- Froin's G95.89
- frontal lobe F07.0
- Fukuhara E88.49
- Gaisböck's D75.1
- ganglion (basal ganglia brain) G25.9
- Gardner-Diamond D69.2
- gastrojejunal loop obstruction K91.89
- Gee-Herter-Heubner K90.0
- Gelineau's G47.419
- genito-anorectal A55
- Gerstmann-Sträussler-Scheinker (GSS) A81.82
- Gianotti-Crosti L44.4
- giant platelet (Bernard-Soulier) D69.19
- Gilles de la Tourette's F95.2
- Glass Q87.89
- Gleich's D72.118
- goiter-deafness E07.1
- Goldberg Q89.89
- Goldberg-Maxwell E34.51
- Good's D83.8
- Gopalan's (burning feet) E53.8
- Gorlin's Q87.89
- Gougerot-Blum L81.7
- Gouley's I31.1
- Gower's R55
- gray or grey (newborn) P93.0
- Gubler-Millard G46.3
- Guillain-Barré (-Strohl) G61.0
- Gulf war T75.830
- gustatory sweating G50.8
- Hadfield-Clarke K86.89
- Hamman's J98.19
- hand-foot L27.1
- hand-shoulder G90.89
- hantavirus (cardio)-pulmonary (HPS) (HCPS) B33.4
- Hao-Fountain (HAFOUS) Q87.87
- happy puppet Q93.51
- Harada's H30.81
- Hayem-Faber D50.9
- headache NEC G44.89
- Heberden's I20.89
- Hedinger's E34.01
- Hegglin's D72.0
- HELLP (hemolysis, elevated liver enzymes and low platelet count) O14.2
- hemolytic-uremic D59.30
- hemophagocytic, infection-associated D76.2
- Henoch-Schönlein D69.0
- hepatic flexure K59.89
- hepatopulmonary K76.81
- hepatorenal K76.7
- hepatourologic K76.7
- hereditary alpha tryptasemia D89.44
- Herter (-Gee) (nontropical sprue) K90.0
- Heubner-Herter K90.0
- Heyd's K76.7
- Hilger's G90.09
- histiocytic D76.3
- histiocytosis NEC D76.3
- HIV infection, acute B20
- Hoffmann-Werdnig G12.0
- Hollander-Simons E88.19
- Hoppe-Goldflam G70.00
- Horner's G90.2
- hungry bone E83.81
- hunterian glossitis D51.0
- Hunt's (herpetic geniculate ganglionitis) (neuralgia) B02.21
- Hutchinson's triad A50.53
- hyperabduction G54.0
- hyperammonemia-hyperornithinemia-homocitrullinemia E72.4
- hypereosinophilic (HES) D72.119
- hyperimmunoglobulin D M04.1
- hyperimmunoglobulin E (IgE) D82.4
- hyperkalemic E87.5
- hypermobility M35.7
- hypernatremia E87.0
- hyperosmolarity (see also, Diabetes, by type, with hyperosmolarity) E87.0
- hyperperfusion G97.82
- hypersplenic D73.1
- hypertransfusion, newborn P61.1
- hyperventilation F45.8
- hypoglycemic (familial) (neonatal) E16.2
- hypokalemic E87.6
- hyponatremic E87.1
- hypopituitarism E23.0
- hypoplastic left-heart Q23.4
- hypopotassemia E87.6
- hyposmolality E87.1
- hypotension, maternal O26.5
- hypothenar hammer I73.89
- hypoventilation, obesity (OHS) E66.2
- ICF (intravascular coagulation-fibrinolysis) D65
- iliotibial band M76.3
- immobility, immobilization (paraplegic) M62.3
- immune effector cell-associated neurotoxicity (ICANS) G92.00
- immune reconstitution D89.3
- immune reconstitution inflammatory [IRIS] D89.3
- immunity deficiency, combined D81.9
- impending coronary I20.0
- impingement, shoulder M75.4
- inappropriate secretion of antidiuretic hormone E22.2
- infantilism (pituitary) E23.0
- inferior vena cava I87.1
- inherited neoplasm predisposition syndrome of multiple systems, specified NEC QA1.798
- inspissated bile (newborn) P59.1
- institutional (childhood) F94.2
- insufficient sleep F51.12
- intermediate coronary (artery) I20.0
- intravascular coagulation-fibrinolysis (ICF) D65
- iodine-deficiency, congenital E00.9
- IRDS (idiopathic respiratory distress, newborn) P22.0
- IVC (intravascular coagulopathy) D65
- Ivemark's Q89.01
- Jackson's G83.89
- jaw-winking Q07.8
- Jervell-Lange-Nielsen I45.81
- jet lag G47.25
- Job's D71.8
- Joseph-Diamond-Blackfan D61.01
- jugular foramen G52.7
- Kabuki (type 1, due to KMT2D mutation) (type 2, due to KDM6A mutation) Q89.81
- Kanner's (autism) F84.0
- Kartagener's Q89.3
- Kelly's D50.1
- Kleefstra Q87.86
- Klein (e) -Levine G47.13
- Klippel-Feil (brevicollis) Q76.1
- König's K59.89
- Korsakoff (-Wernicke) (nonalcoholic) F04
- Kostmann's D70.0
- Krabbe's congenital muscle hypoplasia Q79.8
- lacunar NEC G46.7
- Lambert-Eaton G70.80
- Larsen's Q74.8
- Lassueur Graham-Little Piccardi L66.19
- Launois' E22.0
- Laurence-Moon Q87.84
- Lawrence E88.12
- Lemierre I80.8
- Lennox-Gastaut G40.812
- lenticular, progressive E83.01
- Leopold-Levi's E05.90
- Lev's I44.2
- Li-Fraumeni QA1.792
- Lichtheim's D51.0
- Lightwood's N25.89
- Lignac (de Toni) (-Fanconi) (-Debré) E72.09
- Likoff's I20.89
- limbic epilepsy personality F07.0
- liver-kidney K76.7
- lobotomy F07.0
- Loeys-Dietz Q87.A
- Löffler's J82.89
- long arm 18 or 21 deletion Q93.89
- long QT I45.81
- Louis-Barré G11.3
- lower radicular, newborn (birth injury) P14.8
- Luetscher's (dehydration) E86.0
- Lupus anticoagulant D68.62
- Lutembacher's Q21.19
- Lynch (due to EPCAM) (due to MLH1) (due to MSH2) (due to MSH6) (due to PMS2) QA1.71
- macrophage activation D76.1
- magnesium-deficiency R29.0
- Majeed M04.8
- Mal de Debarquement R42
- malabsorption K90.9
- Mallory-Weiss K22.6
- mandibulofacial dysostosis Q75.4
- maple-syrup-urine E71.0
- Marable's I77.4
- Marfan Q87.40
- Marie's (acromegaly) E22.0
- May (-Hegglin) D72.0
- McArdle (-Schmidt) (-Pearson) E74.04
- McQuarrie's E16.2
- meconium plug (newborn) P76.0
- MED13L (mediator complex subunit 13L) Q87.85
- median arcuate ligament I77.4
- mediator complex subunit 13L (MED13L) Q87.85
- Meekeren-Ehlers-Danlos Q79.6
- megavitamin-B6 E67.2
- Meige G24.4
- MELAS E88.41
- Mendelson's O74.0
- MERRF (myoclonic epilepsy associated with ragged-red fibers) E88.42
- metabolic E88.810
- metastatic carcinoid E34.00
- micrognathia-glossoptosis Q87.0
- midbrain NEC G93.89
- middle lobe (lung) J98.19
- middle radicular G54.0
- migraine G43.909
- Mikulicz' K11.8
- milk-alkali E83.52
- Millard-Gubler G46.3
- Miller-Dieker Q93.88
- Miller-Fisher G61.0
- Minkowski-Chauffard D58.0
- Mirizzi's K83.1
- MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy) E88.49
- monofixation H50.42
- Morel-Moore M85.2
- Morel-Morgagni M85.2
- Morgagni (-Morel) (-Stewart) M85.2
- Morgagni-Adams-Stokes I45.9
- Muckle-Wells M04.2
- mucocutaneous lymph node (acute febrile) (MCLS) M30.3
- multisystem inflammatory (in adults) (in children) M35.81
- Mounier-Kuhn Q32.4
- myasthenic G70.9
- myelodysplastic D46.9
- myeloid hypereosinophilic D72.118
- myelopathic pain G89.0
- myeloproliferative (chronic) D47.1
- myofascial pain M79.18
- Naffziger's G54.0
- nail patella Q87.2
- NARP (Neuropathy, Ataxia and Retinitis pigmentosa) E88.49
- neonatal abstinence P96.1
- nephrotic (congenital) N04.9
- neurologic neglect R41.4
- Nezelof's D81.4
- Niikawa-Kuroki Q89.81
- Nonne-Milroy-Meige Q82.0
- Nothnagel's vasomotor acroparesthesia I73.89
- obesity hypoventilation (OHS) E66.2
- oculomotor H51.9
- Ogilvie K59.81
- Oliver-McFarlane Q87.89
- oral allergy T78.19
- oral-facial-digital Q87.0
- Ormond's N13.5
- oro-facial-digital Q87.0
- os trigonum Q68.8
- Osler-Weber-Rendu I78.0
- osteoporosis-osteomalacia M83.8
- Osterreicher-Turner Q87.2
- oto-palatal-digital Q87.0
- outlet (thoracic) G54.0
- Owren's D68.2
- Paget-Schroetter I82.890
- paralytic G83.9
- Parinaud's H51.0
- paroxysmal facial pain G50.0
- Parry's E05.00
- Parsonage (-Aldren) -Turner G54.5
- patella clunk M25.86
- Paterson (-Brown) (-Kelly) D50.1
- pectoral girdle I77.89
- pectoralis minor I77.89
- pediatric acute-onset neuropsychiatric (PANS) D89.89
- pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) D89.89
- pediatric inflammatory multisystem M35.81
- Pelger-Huet D72.0
- pellagra-cerebellar ataxia-renal aminoaciduria E72.02
- pellagroid E52
- pelvic congestion-fibrosis, female N94.89
- penta X Q97.1
- perabduction I77.89
- periodic fever M04.1
- periodic fever, aphthous stomatitis, pharyngitis, and adenopathy [PFAPA] M04.8
- periurethral fibrosis N13.5
- Peutz-Jeghers Q85.89
- phantom limb (without pain) G54.7
- pharyngeal pouch D82.1
- Phelan-McDermid Q93.52
- Pickwickian E66.2
- PIE (pulmonary infiltration with eosinophilia) J82.89
- pigmentary pallidal degeneration (progressive) G23.0
- pineal E34.8
- pituitary E22.0
- plantar fascia M72.2
- plateau iris (post-iridectomy) (postprocedural) H21.82
- Plummer-Vinson D50.1
- pluricarential of infancy E40
- plurideficiency E40
- pluriglandular (compensatory) E31.8
- pneumatic hammer T75.21
- polyangiitis overlap M30.8
- polycarential of infancy E40
- polyglandular E31.8
- polysplenia Q89.09
- pontine NEC G93.89
- postbacterial fatigue G93.39
- postcardiotomy I97.0
- postcholecystectomy K91.5
- postcommissurotomy I97.0
- postconcussional F07.81
- postcontusional F07.81
- post-COVID (-19) U09.9
- postencephalitic F07.89
- post endometrial ablation N99.85
- post-polypectomy coagulation K91.89
- postgastrectomy (dumping) K91.1
- postgastric surgery K91.1
- postinfarction I24.1
- postinfectious fatigue G93.39
- postlaminectomy NEC M96.1
- postleukotomy F07.0
- postmastectomy lymphedema I97.2
- postmyocardial infarction I24.1
- postoperative NEC T81.9
- postpartum panhypopituitary (Sheehan) E23.0
- postpolio (myelitic) G14
- postthrombotic I87.009
- postvagotomy K91.1
- postvalvulotomy I97.0
- postviral NEC G93.31
- Potain's K31.0
- potassium intoxication E87.5
- Prader-Willi Q87.11
- Prader-Willi-like Q87.19
- precerebral artery (multiple) (bilateral) G45.2
- preinfarction I20.0
- preleukemic D46.9
- premature senility E34.8
- premenstrual dysphoric F32.81
- premenstrual tension N94.3
- Prinzmetal-Massumi R07.1
- prune belly Q79.4
- pseudoparalytica G70.00
- pseudo -Turner's Q87.19
- psycho-organic (nonpsychotic severity) F07.9
- PTEN (hamartoma) tumor Q85.81
- Putnam-Dana D51.0
- pyogenic arthritis, pyoderma gangrenosum, and acne [PAPA] M04.8
- pyramidopallidonigral G20.C
- QT interval prolongation I45.81
- rapid time-zone change G47.25
- Rasmussen G04.81
- Raymond (-Céstan) I65.8
- Raynaud's I73.00
- RDS (respiratory distress syndrome, newborn) P22.0
- reactive airways dysfunction J68.3
- Refsum's G60.1
- Reifenstein E34.52
- Rendu-Osler-Weber I78.0
- residual ovary N99.83
- resistant ovary E28.39
- restless legs G25.81
- restrictive allograft J4A.0
- retinoblastoma (familial) C69.2
- retroperitoneal fibrosis K68.2
- retroviral seroconversion (acute) Z21
- Reye's G93.7
- Ridley's I50.1
- Romano-Ward (prolonged QT interval) I45.81
- rotator cuff, shoulder M75.10
- rubella (congenital) P35.0
- Ruvalcaba-Myhre-Smith E71.440
- Rytand-Lipsitch I44.2
- salt-losing N28.89
- SATB2-associated Q87.89
- Scaglietti-Dagnini E22.0
- scalenus anticus (anterior) G54.0
- scapuloperoneal G71.09
- schizophrenic, of childhood NEC F20.9
- Schnitzler D47.2
- Scholte's E34.09
- Schroeder's E27.0
- Schüller-Christian C96.5
- Schwachman (-Diamond) D61.02
- Schwartz (-Jampel) G71.13
- Schwartz-Bartter E22.2
- scimitar Q26.8
- sclerocystic ovary E28.2
- Seitelberger's G31.89
- septicemic adrenal hemorrhage A39.1
- seroconversion, retroviral (acute) Z21
- serotonin G90.81
- serous meningitis G93.2
- severe acute respiratory (SARS) J12.81
- shaken infant T74.4
- shock (traumatic) T79.4
- shock-lung J80
- Shwachman (-Diamond) D61.02
- sick-euthyroid E07.81
- sideropenic D50.1
- Siemens' ectodermal dysplasia Q82.4
- Silfversköld's Q78.9
- Simons' E88.11
- sinus tarsi M25.57
- sinusitis-bronchiectasis-situs inversus Q89.3
- Sipple's E31.22
- sirenomelia Q87.2
- Sjögren M35.00
- Slocumb's E27.0
- slow flow, coronary I20.89
- Sluder's G44.89
- Smith-Magenis Q93.88
- Sneddon-Wilkinson L13.1
- Snyder-Robinson Q87.89
- Soto's Q87.3
- South African cardiomyopathy I42.89
- Spen's I45.9
- Spurway's Q78.0
- staphylococcal scalded skin L00
- Stein-Leventhal E28.2
- Stein's E28.2
- Stevens-Johnson syndrome L51.1
- Stewart-Morel M85.2
- Stickler Q89.89
- stiff baby Q89.89
- stiff man G25.82
- Stokes (-Adams) I45.9
- stone heart I50.1
- straight back, congenital Q76.49
- Sturge-Weber (-Dimitri) Q85.89
- subclavian steal G45.8
- subcoracoid-pectoralis minor G54.0
- subcostal nerve compression I77.89
- subphrenic interposition Q43.3
- suprarenal cortical E27.0
- supraspinatus M75.10
- Susac G93.49
- swallowed blood P78.2
- sweat retention L74.0
- Swyer Q99.1
- Symond's G93.2
- systemic inflammatory response (SIRS), of non-infectious origin (without organ dysfunction) R65.10
- tachycardia-bradycardia I49.5
- takotsubo I51.81
- TAR (thrombocytopenia with absent radius) Q87.2
- tarsal tunnel G57.5
- teething K00.7
- tegmental G93.89
- telangiectasic-pigmentation-cataract Q82.8
- temporomandibular joint-pain-dysfunction M26.62
- Terry's H44.2
- testicular feminization E34.51
- thalamic pain (hyperesthetic) G89.0
- thoracic outlet (compression) G54.0
- Thorson-Björck E34.09
- thrombocytopenia with absent radius (TAR) Q87.2
- thrombosis with thrombocytopenia D75.84
- thyroid-adrenocortical insufficiency E31.0
- Tietze's M94.0
- time-zone (rapid) G47.25
- Toni-Fanconi E72.09
- Touraine's Q79.8
- toxic shock A48.3
- transient left ventricular apical ballooning I51.81
- traumatic vasospastic T75.22
- Treacher Collins Q75.4
- triple X, female Q97.0
- trisomy Q92.9
- tropical wet feet T69.02
- Trousseau's I82.1
- tumor lysis (following antineoplastic chemotherapy) (spontaneous) NEC E88.3
- tumor necrosis factor receptor associated periodic (TRAPS) M04.1
- upward gaze H51.8
- uremia, chronic N18.9
- urethral N34.3
- urohepatic K76.7
- usher Q99.819
- vacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic (VEXAS) M04.3
- vago-hypoglossal G52.7
- vanishing twin of one fetus or more O31.4
- vascular NEC in cerebrovascular disease G46.8
- vasoconstriction, reversible cerebrovascular I67.841
- vasomotor I73.9
- vasospastic (traumatic) T75.22
- vasovagal R55
- van Buchem's M85.2
- van der Hoeve's Q78.0
- VATER Q87.2
- velo-cardio-facial Q93.81
- vena cava (inferior) (superior) (obstruction) I87.1
- vertebro-basilar artery G45.0
- vertebrogenic (pain) M54.89
- VEXAS (vacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic) M04.3
- Vinson-Plummer D50.1
- virus B34.9
- visceral larva migrans B83.0
- visual disorientation H53.8
- vitamin B6 deficiency E53.1
- vitreal corneal H59.01
- vitreous (touch) H59.01
- Vogt-Koyanagi H20.82
- Volkmann's T79.6
- von Hippel-Lindau Q85.83
- von Schroetter's I82.890
- Waldenström-Kjellberg D50.1
- Wallenberg's G46.3
- wasting (syndrome) due to underlying condition E88.A
- water retention E87.79
- Waterhouse (-Friderichsen) A39.1
- Weber-Gubler G46.3
- Weber-Leyden G46.3
- Weber's G46.3
- Wegener's M31.30
- Weingarten's (tropical eosinophilia) J82.89
- Weiss-Baker G90.09
- Werdnig-Hoffman G12.0
- Wermer's E31.21
- Werner's E34.8
- Wernicke-Korsakoff (nonalcoholic) F04
- Westphal-Strümpell E83.01
- whiplash S13.4
- whistling face Q87.0
- Wilkie's K55.1
- Wilkinson-Sneddon L13.1
- Williams Q93.82
- Wilson's (hepatolenticular degeneration) E83.01
- Wiskott-Aldrich D82.0
- Woakes' (ethmoiditis) J33.1
- Wright's (hyperabduction) G54.0
- X I20.9
- XXXX Q97.1
- XXXXX Q97.1
- XXXXY Q98.1
- XXY Q98.0
- Yao M04.8
- yellow nail L60.5
- Zahorsky's B08.5
- Zellweger syndrome E71.510
- Zellweger-like syndrome E71.541
Index entries, exactly as the book files them. This says they are listed together — not that any of them is documented in your chart.
How to use this page
Everything the published sources say about one code, on one page.
- Read the Excludes1 block first — it is the one that stops you coding this at all alongside another code.
- Excludes2, Code first, Use additional and Includes follow. A note inherited from a parent category is labelled with the category it came from, so you can see why it applies.
- Official Guidelines sit below. "Guidelines naming this code" cite the code or a range containing it; "Chapter guidance" is the general guidance for its chapter and is the weaker signal.
- Guideline text is quoted verbatim with its section number and page, so you can check it against the published document.
- Risk-model chips show which published CMS models map this code.
What this page does not do
- Guidance is quoted, never paraphrased — a paraphrase of a coding rule is a different rule.
- Medication candidates, where shown, are matched by condition *name* and are offered as candidates for you to judge. They are not "the drugs for this code".
Exclusions6never code together
- carrier or suspected carrier of infectious disease (Z22.-)Z22.-
- certain localized infections - see body system-related chapters
- infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium (O98.-)O98.-
- infectious and parasitic diseases specific to the perinatal period (P35-P39)P35-P39
- influenza and other acute respiratory infections (J00-J22)J00-J22
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes3
Official Guidelines24
ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.
If the term “AIDS” or “HIV disease” is documented or if the patient is treated for any HIV-related illness or is described as having any condition(s) resulting from the patient’s HIV positive status; code B20, Human immunodeficiency virus [HIV], should be assigned.
If a patient is admitted for an HIV-related condition, the principal diagnosis should be B20, Human immunodeficiency virus [HIV] disease followed by additional diagnosis codes for all reported HIV-related conditions. An exception to this guideline is if the reason for admission is hemolytic-uremic syndrome associated with HIV disease. Assign code D59.31, Infection-associated hemolytic-uremic syndrome, followed by code B20, Human immunodeficiency virus [HIV] disease.
If a patient with HIV disease is admitted for an unrelated condition (such as a traumatic injury), the code for the unrelated condition (e.g., the nature of injury code) should be the principal diagnosis. Code B20 would be reported as a secondary diagnosis. Codes for other documented conditions should also be reported as secondary diagnoses.
Whether the patient is newly diagnosed or has had previous admissions/encounters for HIV conditions is irrelevant to the sequencing decision.
When “HIV positive,” “HIV test positive,” or similar terminology is documented, and there is no documentation of symptoms or HIV-related illness, code Z21, Asymptomatic human immunodeficiency virus [HIV] infection status, should be assigned.
Patients with documentation of inconclusive HIV serology, may be assigned code R75, Inconclusive laboratory evidence of human immunodeficiency virus [HIV]. (g) Previously diagnosed HIV-related illness Patients with documentation of a prior diagnosis of an HIV-related illness should be coded to B20. Once an HIV-related illness has developed, code B20 should always be assigned on every subsequent admission/encounter. Patients previously diagnosed with any HIV illness (B20) should never be assigned to R75, Inconclusive laboratory evidence of human immunodeficiency virus [HIV] or Z21, Asymptomatic human immunodeficiency virus [HIV] infection status. (h) HIV Infection in Pregnancy, Childbirth and the Puerperium When a patient presents during pregnancy, childbirth or the puerperium with documented symptomatic HIV disease or an HIV related illness, assign a code from subcategory O98.7, Human immunodeficiency [HIV] disease complicating pregnancy, childbirth and the puerperium, followed by code B20 and additional code(s) for any HIV-related illness(es). Codes from Chapter 15 always take sequencing priority. When a patient presents during pregnancy, childbirth or the puerperium with documented asymptomatic HIV infection status or is HIV-positive, assign a code from subcategory O98.7 followed by code Z21.
If a patient without signs or symptoms is tested for HIV, assign code Z11.4, Encounter for screening for human immunodeficiency virus [HIV]. Use additional codes for any associated high-risk behavior, if applicable. If a patient with signs or symptoms of HIV presents for HIV testing, code the signs and symptoms. An additional counseling code Z71.7, Human immunodeficiency virus [HIV] counseling, may be assigned if counseling is provided during the encounter for the test. Code Z11.4, Encounter for screening for human immunodeficiency virus [HIV], should not be assigned if HIV signs or symptoms are present. When a patient presents for follow up regarding their HIV test results and the test result is negative, assign code Z71.7, Human immunodeficiency virus [HIV] counseling. If the results are positive, see previous guidelines and assign codes as appropriate. (j) HIV disease or HIV positive status managed by antiretroviral medication If a patient with documented HIV disease, HIV-related illness or AIDS is currently managed on antiretroviral medications, assign code B20, Human immunodeficiency virus [HIV] disease. If a patient with documented HIV positive status is currently managed on antiretroviral medication, assign code Z21, Asymptomatic human immunodeficiency virus [HIV] infection status, in the absence of any additional documentation of HIV disease, HIV-related illness or AIDS. Code Z79.899, Other long term (current) drug therapy, may be assigned as an additional code to identify the long-term (current) use of antiretroviral medications. (k) Encounter for HIV Prophylaxis Measures When a patient presents for administration of pre-exposure prophylaxis medication for HIV, assign code Z29.81, Encounter for HIV pre-exposure prophylaxis. Pre-exposure prophylaxis (PrEP) is intended to prevent infection in people who are at risk for getting HIV through sex or injection drug use. Any risk factors for HIV should also be coded.
Certain infections are classified in chapters other than Chapter 1 and no organism is identified as part of the infection code. In these instances, it is necessary to use an additional code from Chapter 1 to identify the organism. A code from category B95, Streptococcus, Staphylococcus, and Enterococcus as the cause of diseases classified to other chapters, B96, Other bacterial agents as the cause of diseases classified to other chapters, or B97, Viral agents as the cause of diseases classified to other chapters, is to be used as an additional code to identify the organism. An instructional note will be found at the infection code advising that an additional organism code is required.
Many bacterial infections are resistant to current antibiotics. It is necessary to identify all infections documented as antibiotic resistant. Assign a code from category Z16, Resistance to antimicrobial drugs, following the infection code only if the infection code does not identify drug resistance.
For a diagnosis of sepsis, assign the appropriate code for the underlying systemic infection. If the type of infection or causal organism is not further specified, assign code A41.9, Sepsis, unspecified organism. A code from subcategory R65.2, Severe sepsis, should not be assigned unless severe sepsis or an associated acute organ dysfunction is documented. (i) Negative or inconclusive blood cultures and sepsis Negative or inconclusive blood cultures do not preclude a diagnosis of sepsis in patients with clinical evidence of the condition; however, the provider should be queried. (ii) Urosepsis The term urosepsis is a nonspecific term. It is not to be considered synonymous with sepsis. It has no default code in the Alphabetic Index. Should a provider use this term, he/she must be queried for clarification. (iii) Sepsis with organ dysfunction If a patient has sepsis and associated acute organ dysfunction or multiple organ dysfunction (MOD), follow the instructions for coding severe sepsis. (iv)Acute organ dysfunction that is not clearly associated with the sepsis If a patient has sepsis and an acute organ dysfunction, but the medical record documentation indicates that the acute organ dysfunction is related to a medical condition other than the sepsis, do not assign a code from subcategory R65.2, Severe sepsis. An acute organ dysfunction must be associated with the sepsis in order to assign the severe sepsis code. If the documentation is not clear as to whether an acute organ dysfunction is related to the sepsis or another medical condition, query the provider.
The coding of severe sepsis requires a minimum of 2 codes: first a code for the underlying systemic infection, followed by a code from subcategory R65.2, Severe sepsis. If the causal organism is not documented, assign code A41.9, Sepsis, unspecified organism, for the infection. Additional code(s) for the associated acute organ dysfunction are also required. Due to the complex nature of severe sepsis, some cases may require querying the provider prior to assignment of the codes.
Septic shock generally refers to circulatory failure associated with severe sepsis, and therefore, it represents a type of acute organ dysfunction. For cases of septic shock, the code for the systemic infection should be sequenced first, followed by code R65.21, Severe sepsis with septic shock or code T81.12, Postprocedural septic shock. Any additional codes for the other acute organ dysfunctions should also be assigned. As noted in the sequencing instructions in the Tabular List, the code for septic shock cannot be assigned as a principal diagnosis.
If severe sepsis is present on admission, and meets the definition of principal diagnosis, the underlying systemic infection should be assigned as principal diagnosis followed by the appropriate code from subcategory R65.2 as required by the sequencing rules in the Tabular List. A code from subcategory R65.2 can never be assigned as a principal diagnosis. When severe sepsis develops during an encounter (it was not present on admission), the underlying systemic infection and the appropriate code from subcategory R65.2 should be assigned as secondary diagnoses. Severe sepsis may be present on admission, but the diagnosis may not be confirmed until sometime after admission. If the documentation is not clear whether severe sepsis was present on admission, the provider should be queried. For infection-associated hemolytic-uremic syndrome with severe sepsis, see guideline I.C.1.d.9.
If the reason for admission is sepsis or severe sepsis and a localized infection, such as pneumonia or cellulitis, a code(s) for the underlying systemic infection should be assigned first and the code for the localized infection should be assigned as a secondary diagnosis. If the patient has severe sepsis, a code from subcategory R65.2 should also be assigned as a secondary diagnosis. If the patient is admitted with a localized infection, such as pneumonia, and sepsis/severe sepsis doesn’t develop until after admission, the localized infection should be assigned first, followed by the appropriate sepsis/severe sepsis codes. For hemolytic-uremic syndrome associated with sepsis, see guideline I.C.1.d.9.
As with all postprocedural complications, code assignment is based on the provider’s documentation of the relationship between the infection and the procedure.
For sepsis following a postprocedural wound (surgical site) infection, a code from T81.41 to T81.43, Infection following a procedure, T81.49, Infection following a procedure, other surgical site, or a code from O86.00 to O86.03, Infection of obstetric surgical wound, or code O86.09, Infection of obstetric surgical wound, other surgical site, that identifies the site of the infection should be sequenced first, if known. Assign an additional code for sepsis following a procedure (T81.44) or sepsis following an obstetrical procedure (O86.04). Use an additional code to identify the infectious agent. If the patient has severe sepsis, the appropriate code from subcategory R65.2 should also be assigned with the additional code(s) for any acute organ dysfunction. For infections following infusion, transfusion, therapeutic injection, or immunization, a code from subcategory T80.2, Infections following infusion, transfusion, and therapeutic injection, or code T88.0-, Infection following immunization, should be coded first, followed by the code for the specific infection. If the patient has severe sepsis, the appropriate code from subcategory R65.2 should also be assigned, with the additional codes(s) for any acute organ dysfunction.
If a postprocedural infection has resulted in postprocedural septic shock, assign the codes indicated above for sepsis due to a postprocedural infection, followed by code T81.12-, Postprocedural septic shock. Do not assign code R65.21, Severe sepsis with septic shock. Additional code(s) should be assigned for any acute organ dysfunction.
(condition) In some cases, a noninfectious process (condition) such as trauma, may lead to an infection which can result in sepsis or severe sepsis. If sepsis or severe sepsis is documented as associated with a noninfectious condition, such as a burn or serious injury, and this condition meets the definition for principal diagnosis, the code for the noninfectious condition should be sequenced first, followed by the code for the resulting infection. If severe sepsis is present, a code from subcategory R65.2 should also be assigned with any associated organ dysfunction(s) codes. It is not necessary to assign a code from subcategory R65.1, Systemic inflammatory response syndrome (SIRS) of non-infectious origin, for these cases. If the infection meets the definition of principal diagnosis, it should be sequenced before the non-infectious condition. When both the associated non-infectious condition and the infection meet the definition of principal diagnosis, either may be assigned as principal diagnosis. Only one code from category R65, Symptoms and signs specifically associated with systemic inflammation and infection, should be assigned. Therefore, when a non-infectious condition leads to an infection resulting in severe sepsis, assign the appropriate code from subcategory R65.2, Severe sepsis. Do not additionally assign a code from subcategory R65.1, Systemic inflammatory response syndrome (SIRS) of non- infectious origin. See Section I.C.18. SIRS due to non-infectious process
See Section I.C.15. Sepsis and septic shock complicating abortion, pregnancy, childbirth and the puerperium
See Section I.C.16. f. Bacterial sepsis of Newborn
If the reason for admission is hemolytic-uremic syndrome that is associated with sepsis, assign code D59.31, Infection-associated hemolytic-uremic syndrome, as the principal diagnosis. Codes for the underlying systemic infection and any other conditions (such as severe sepsis) should be assigned as secondary diagnoses.
When a patient is diagnosed with an infection that is due to methicillin resistant Staphylococcus aureus (MRSA), and that infection has a combination code that includes the causal organism (e.g., sepsis, pneumonia) assign the appropriate combination code for the condition (e.g., code A41.02, Sepsis due to Methicillin resistant Staphylococcus aureus or code J15.212, Pneumonia due to Methicillin resistant Staphylococcus aureus). Do not assign code B95.62, Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere, as an additional code, because the combination code includes the type of infection and the MRSA organism. Do not assign a code from subcategory Z16.11, Resistance to penicillins, as an additional diagnosis. See Section C.1. for instructions on coding and sequencing of sepsis and severe sepsis.
When there is documentation of a current infection (e.g., wound infection, stitch abscess, urinary tract infection) due to MRSA, and that infection does not have a combination code that includes the causal organism, assign the appropriate code to identify the condition along with code B95.62, Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere for the MRSA infection. Do not assign a code from subcategory Z16.11, Resistance to penicillins.
Index entries leading here8
- Angina (attack) (cardiac) (chest) (heart) (pectoris) (syndrome) (vasomotor) I20.9
- aphthous B08.5
- Pharyngitis (acute) (catarrhal)(gangrenous) (infective) (malignant) (membranous) (phlegmonous) (pseudomembranous) (simple) (subacute) (suppurative) (ulcerative) J02.9
- Sore
- Infection, infected, infective (opportunistic) B99.9
- pharynx — see also Pharyngitis
- coxsackievirus B08.5
- pharynx — see also Pharyngitis
- Coxsackie (virus) (infection) B34.1
- pharyngitis B08.5
- Herpangina B08.5
- Syndrome — see also Disease
- Zahorsky's B08.5
- Zahorsky's syndrome (herpangina) B08.5
Alongside this code8same parent — B08
Medications1
MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.
Additional references
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.